OPCH Stock Recent News
OPCH LATEST HEADLINES
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 1, 2025.
Option Care (OPCH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
Option Care (OPCH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Option Care (OPCH) could produce exceptional returns because of its solid growth attributes.
GILD, OPCH and AVAH demonstrate resilience with impressive earnings surprise history.
These highly ranked medical stocks have the value and essential services that investors may be looking for as tariff concerns and geopolitical tensions have started to rattle markets.
Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?